Display options
Share it on

Mol Ther Nucleic Acids. 2017 Mar 17;6:29-44. doi: 10.1016/j.omtn.2016.12.002. Epub 2016 Dec 10.

Aptamers for CD Antigens: From Cell Profiling to Activity Modulation.

Molecular therapy. Nucleic acids

Amin Nozari, Maxim V Berezovski

Affiliations

  1. Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, ON K1N6N5, Canada.
  2. Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, ON K1N6N5, Canada. Electronic address: [email protected].

PMID: 28325295 PMCID: PMC5363458 DOI: 10.1016/j.omtn.2016.12.002

Abstract

Nucleic acid-based aptamers are considered to be a promising alternative to antibodies because of their strong and specific binding to diverse targets, fast and inexpensive chemical synthesis, and easy labeling with a fluorescent dye or therapeutic agent. Cluster of differentiation (CD) proteins are among the most popular antigens for aptamers on the cell surface. These anti-CD aptamers could be used in cell biology and biomedicine, from simple cell phenotyping by flow cytometry or fluorescent microscopy to diagnosis and treatment of HIV/AIDS to cancer and immune therapies. The unique feature of aptamers is that they can act simultaneously as an agonist and antagonist of CD receptors depending on a degree of aptamer oligomerization. Aptamers can also deliver small interfering RNA to silence vital genes in CD-positive cells. In this review, we summarize nucleic acid sequences of anti-CD aptamers and their use, which have been validated in multiple studies.

Copyright © 2016 The Author(s). Published by Elsevier Inc. All rights reserved.

Keywords: aptamers; cell imaging; cluster of differentiation; drug delivery; siRNA

References

  1. Eur J Med Chem. 2012 Oct;56:396-9 - PubMed
  2. Mol Ther. 2014 Jul;22(7):1375-1387 - PubMed
  3. J Biol Chem. 2011 Jun 17;286(24):21896-905 - PubMed
  4. Nat Rev Immunol. 2004 Jun;4(6):420-31 - PubMed
  5. J Immunol. 1999 Feb 15;162(4):1947-51 - PubMed
  6. Clin Cancer Res. 2001 Jun;7(6):1798-804 - PubMed
  7. Eur J Haematol. 2016 Jul;97(1):39-47 - PubMed
  8. Clin Transl Med. 2013 Jan 17;2(1):3 - PubMed
  9. Cell Immunol. 2014 Jul;290(1):72-9 - PubMed
  10. Nat Rev Immunol. 2002 Aug;2(8):569-79 - PubMed
  11. ACS Nano. 2015 Mar 24;9(3):2235-54 - PubMed
  12. Am J Clin Pathol. 2010 Oct;134(4):586-93 - PubMed
  13. J Leukoc Biol. 2006 Aug;80(2):227-36 - PubMed
  14. Mol Ther. 2012 Jun;20(6):1242-50 - PubMed
  15. Trends Immunol. 2002 Feb;23(2):102-9 - PubMed
  16. J Clin Invest. 2014 Jul;124(7):2977-87 - PubMed
  17. J Exp Med. 2006 Oct 30;203(11):2461-72 - PubMed
  18. Curr Opin Immunol. 2008 Aug;20(4):444-9 - PubMed
  19. Nat Rev Cancer. 2007 Feb;7(2):95-106 - PubMed
  20. Mol Ther Nucleic Acids. 2015 Apr 28;4:e237 - PubMed
  21. J Immunol Methods. 2007 Jan 30;319(1-2):1-5 - PubMed
  22. Science. 2001 Sep 14;293(5537):2108-11 - PubMed
  23. Mol Ther. 2013 Jul;21(7):1378-89 - PubMed
  24. Toxins (Basel). 2014 Feb 28;6(3):869-91 - PubMed
  25. Ther Deliv. 2013 Dec;4(12):1527-46 - PubMed
  26. Adv Exp Med Biol. 2000;465:355-62 - PubMed
  27. Int J Biochem Cell Biol. 2014 Jun;51:10-8 - PubMed
  28. PLoS One. 2012;7(2):e30796 - PubMed
  29. Neoplasia. 2007 Jun;9(6):479-86 - PubMed
  30. J Immunol. 1998 Jun 1;160(11):5209-12 - PubMed
  31. Am J Clin Oncol. 2016 Feb;39(1):98-106 - PubMed
  32. Angew Chem Int Ed Engl. 2014 Sep 22;53(39):10541-4 - PubMed
  33. PLoS One. 2009;4(4):e5219 - PubMed
  34. Lab Invest. 2009 Dec;89(12):1423-32 - PubMed
  35. Mod Pathol. 2010 Dec;23(12):1553-8 - PubMed
  36. PLoS One. 2014 May 19;9(5):e98315 - PubMed
  37. Nat Rev Immunol. 2009 Mar;9(3):162-74 - PubMed
  38. Nucleic Acid Ther. 2013 Feb;23(1):35-43 - PubMed
  39. Biomaterials. 2016 Jun;91:73-80 - PubMed
  40. J Exp Med. 2000 Oct 2;192(7):1027-34 - PubMed
  41. PLoS One. 2008 Mar 05;3(3):e1708 - PubMed
  42. Mol Ther Nucleic Acids. 2014 Jan 21;3:e143 - PubMed
  43. J Nanobiotechnology. 2011 Jan 31;9:2 - PubMed
  44. Biomaterials. 2015 Oct;67:274-85 - PubMed
  45. J Allergy Clin Immunol. 2013 Sep;132(3):713-722.e11 - PubMed
  46. RNA Biol. 2012 Jan;9(1):67-80 - PubMed
  47. RNA Biol. 2015;12(9):1043-53 - PubMed
  48. J Leukoc Biol. 2013 Jul;94(1):41-53 - PubMed
  49. Cancer Res. 2003 Nov 1;63(21):7483-9 - PubMed
  50. J Cell Biol. 2013 Feb 18;200(4):373-83 - PubMed
  51. Trends Microbiol. 2007 Apr;15(4):143-6 - PubMed
  52. Nat Genet. 2001 Jan;27(1):68-73 - PubMed
  53. Cancer Res. 2012 Mar 15;72(6):1373-83 - PubMed
  54. Expert Opin Biol Ther. 2001 May;1(3):375-83 - PubMed
  55. Stem Cells Int. 2016;2016:2087204 - PubMed
  56. Exp Hematol. 2004 Apr;32(4):382-9 - PubMed
  57. Biochemistry. 2010 Oct 26;49(42):9106-12 - PubMed
  58. Blood Rev. 2013 Sep;27(5):217-23 - PubMed
  59. J Exp Med. 2005 Mar 7;201(5):779-91 - PubMed
  60. Nucleic Acids Res. 2004 Nov 23;32(20):6120-8 - PubMed
  61. Nat Rev Immunol. 2003 Aug;3(8):609-20 - PubMed
  62. J Hematol Oncol. 2015 Jul 10;8:83 - PubMed
  63. Oncotarget. 2016 Jan 26;7(4):4522-30 - PubMed
  64. J Nucleic Acids. 2012;2012:748913 - PubMed
  65. Clin Cancer Res. 2013 Mar 1;19(5):1035-43 - PubMed
  66. Cancer Res. 1997 Sep 15;57(18):4036-41 - PubMed
  67. Viruses. 2015 Jul 27;7(8):4186-203 - PubMed
  68. J Biol Chem. 2012 Apr 20;287(17):13829-39 - PubMed
  69. Cell Res. 2005 Sep;15(9):691-4 - PubMed
  70. J Clin Invest. 2014 Jan;124(1):188-97 - PubMed
  71. Cancer Res. 2005 Apr 15;65(8):3437-46 - PubMed
  72. Methods Mol Biol. 2014;1060:37-59 - PubMed
  73. J Clin Invest. 2011 Jun;121(6):2401-12 - PubMed
  74. Oncotarget. 2016 Apr 26;7(17):23182-96 - PubMed
  75. J Extracell Vesicles. 2015 Mar 02;4:26659 - PubMed
  76. Ann Rheum Dis. 2005 Nov;64 Suppl 4:iv91-5 - PubMed
  77. Chem Biol. 2015 Mar 19;22(3):379-90 - PubMed
  78. Neoplasia. 2004 Jul-Aug;6(4):343-53 - PubMed
  79. Immunity. 2015 Sep 15;43(3):579-90 - PubMed
  80. Expert Opin Drug Metab Toxicol. 2009 Dec;5(12):1529-42 - PubMed
  81. Nat Rev Cancer. 2012 Mar 22;12(4):252-64 - PubMed
  82. Langmuir. 2012 Aug 28;28(34):12544-9 - PubMed
  83. J Exp Med. 1994 Jul 1;180(1):157-63 - PubMed
  84. Mol Immunol. 2015 Oct;67(2 Pt A):117-30 - PubMed
  85. Mol Ther Nucleic Acids. 2013 Jun 11;2:e98 - PubMed
  86. Clin Pharmacol Ther. 2010 Apr;87(4):396-8 - PubMed
  87. J Clin Invest. 2008 Jan;118(1):376-86 - PubMed
  88. Immunopharmacol Immunotoxicol. 2014 Apr;36(2):96-104 - PubMed
  89. Nucleic Acids Res. 2013 Apr;41(7):4266-83 - PubMed
  90. Cancer Res. 2005 Feb 1;65(3):1089-96 - PubMed
  91. Molecules. 2015 Apr 16;20(4):6866-87 - PubMed
  92. Nat Biotechnol. 2006 Aug;24(8):1005-15 - PubMed
  93. Cancer Res. 2010 Oct 15;70(20):7800-9 - PubMed
  94. Cancer Sci. 2005 Aug;96(8):487-97 - PubMed
  95. Nat Immunol. 2001 Mar;2(3):261-8 - PubMed
  96. Nat Rev Immunol. 2006 Oct;6(10):715-27 - PubMed
  97. RNA Biol. 2014;11(1):57-65 - PubMed
  98. J Exp Med. 2010 Sep 27;207(10):2187-94 - PubMed
  99. Biochem Biophys Res Commun. 2014 Oct 3;452(4):1040-5 - PubMed
  100. Biosens Bioelectron. 2015 Sep 15;71:230-242 - PubMed
  101. Am J Clin Pathol. 2010 Oct;134(4):529-31 - PubMed
  102. Adv Immunol. 2006;90:51-81 - PubMed
  103. Analyst. 2015 Aug 21;140(16):5379-99 - PubMed
  104. Nucleic Acids Res. 1998 Sep 1;26(17):3915-24 - PubMed
  105. Annu Rev Immunol. 2005;23:23-68 - PubMed
  106. Int J Mol Sci. 2016 Jul 18;17(7): - PubMed
  107. Chem Biol. 2008 Jul 21;15(7):675-82 - PubMed
  108. Blood. 2009 Apr 16;113(16):3716-25 - PubMed
  109. Science. 1996 Mar 22;271(5256):1734-6 - PubMed

Publication Types